July 6, 2021, Vol 326, No. 1, Pages 11-96
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living FacilitiesA Randomized Clinical Trial
Myron S. Cohen, MD; Ajay Nirula, MD, PhD; Mark J. Mulligan, MD; et al.
free access has active quiz
JAMA. 2021;326(1):46-55. doi:10.1001/jama.2021.8828
This randomized clinical trial assesses the effect of a single intravenous infusion of bamlanivimab vs placebo on incidence of COVID-19 among residents and staff of skilled nursing and assisted living facilities.